Healthy adult
Conditions
Interventions
Subjects use the test product twice daily for 24 weeks.
Sponsors
Yamada Bee Company, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [1]Healthy Japanese males and females aged between 30 and 60 at the time of informed consent [2]Subjects with feeling of thinning hair and hair loss [3]Subjects who don't have full head of gray hair or are dyeing gray hair [4]Subjects who can agree to cut hair locally approximately 1.0 cm x 1.0 cm near the crown on each visit day [5]Subjects who can agree to keep the conditions such as hair conditioning and hair dyeing constant on each visit day [6]Subjects who can obtain written consent at their own discretion before the study begins
Exclusion criteria
Exclusion criteria: [1]Subjects with pathological hair loss such as alopecia areata [2]Subjects with scalp diseases other than hair loss (eg, head eczema, seborrheic eczema, psoriasis, tinea capitis, and other scalp infections) [3]Subject with reduced or abnormal thyroid function [4]Subjects with photosensitivity disorder [5]Subjects receiving "hormone replacement therapy" or taking oral contraceptives within one year [6]Subjects who are pregnant or lactating, or who intend to become pregnant [7]Subject with atopic dermatitis [8]Subjects who habitually apply or take external preparations, oral medicines, supplements, etc. that may affect the condition of the head [9]Subjects with a history of hypersensitivity (allergies) to hair growth agents, hair restorer, cosmetics (shampoo, etc.), or hypersensitivity to other medicines. [10]Subjects who have been treated with radiation therapy to the head or cancer chemotherapy within the last 6 months, or who will be treated within the next 2 months after the end of the study [11]Subjects who regularly use wigs during the study period, subjects who have undergone hair transplantation or hair growth, or subjects who are scheduled during the study period [12]Subjects who have been treated with pharmaceutical hair growth agents (such as finasteride, minoxidil, or carpronium chloride-containing preparations) within the past 6 months [13]Subjects who have used existing hair growth agents and hair restorer within the past 2 months, regardless of whether they are pharmaceutical products or quasi-drugs. [14]Subjects currently using medical medications known to cause trichotillomania or hirsutism (eg, phenytoin for epilepsy) [15]Subjects working for cosmetics companies and pharmaceutical companies [16]Subjects judged to be ineligible for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Photo Trichogram (Growth rate, Hair diameter, Anagen hair percentage,Hair number) | — |
Secondary
| Measure | Time frame |
|---|---|
| Stratum corneum water content of the scalp,Questionnaire survey,Head photography (front side of head, back side of head),Adverse event investigation | — |
Countries
Japan
Contacts
Public ContactMasaaki Yamamura
Nikoderm Research Inc. Evaluation Division
Outcome results
None listed